Viatris. has been granted a patent for a medicament injection device featuring a housing with a container, needle, and stopper. The device includes a plunger, resilient members, a rotatable carriage, and a skin sensor, facilitating controlled medicament delivery upon application of force. GlobalData’s report on Viatris gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Viatris, Cancer treatment biomarkers was a key innovation area identified from patents. Viatris's grant share as of June 2024 was 57%. Grant share is based on the ratio of number of grants to total number of patents.
Device for injecting medicament using a skin sensor
The patent US12023468B2 describes a novel device designed for the injection of a medicament. The device features a housing that contains a medicament-filled container equipped with a needle and a stopper. A plunger, which engages the stopper, is activated by a first resilient member to facilitate the injection process. The device also includes a rotatable carriage that holds part of the container, a collar that engages the carriage to initiate rotation, and a skin sensor that interacts with a second resilient member. Upon removal of a cap from the housing and application of an injection force to the skin sensor, the second resilient member compresses, causing the collar to rotate the carriage. This action subsequently engages the plunger to inject the medicament through the needle.
Additional claims detail various components and functionalities of the device, including a restraining member on the plunger to maintain the first resilient member in a compressed state, a retractable skin sensor that surrounds the needle post-injection, and a needle shield for safety. The device is designed to be disposable and can accommodate a range of medicaments, including analgesics, anti-inflammatory agents, and hormones, among others. The claims also describe specific mechanisms for the interaction between the cap, needle shield, and skin sensor, ensuring a secure and effective injection process. Overall, the patent outlines a comprehensive system aimed at improving the efficiency and safety of medicament delivery through injection.
To know more about GlobalData’s detailed insights on Viatris, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
